Stryker Q1 net sales $6.0B up 2.6%; adjusted EPS down 8.5% to $2.60; maintains FY guidance

STRYKER CORP

2026-Q1 EPS reported $1.93 revenue$6,020,000,000

Net sales $6.0B (+2.6% reported, +2.4% organic); MedSurg/Neuro +5.0%, Orthopaedics +0.1%.
Reported EPS $1.93 (+14.2%); adjusted EPS $2.60 (-8.5%) as adjusted operating margin contracted 180bps to 21.1%.
Maintains FY2026 guidance: organic sales growth 8.0%-9.5%, adjusted EPS $14.90-$15.10.
Company highlights recovery from cyber incident and new Ortho Tech organizational structure combining Mako and instruments.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.